Personalized medicine: biomarkers and companion diagnostics
Great expectations are bound to the current evolution of medicine to personalized medicine. Thanks to rapid advances in genomics and molecular biology, new markers can be revealed for the presence of or susceptibility to a disease, or response to treatment. On such markers, diagnostic tests can be b...
Main Authors: | Renato Bernardini, Giovanni Gancitano, Angela Balice, Rosaria Di Mauro, Giuseppina Cantarella, Matteo Dionisi |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd Medical Publishers
2018-03-01
|
Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
Subjects: | |
Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1348 |
Similar Items
-
Molecular Pathology and Personalized Medicine: The Dawn of a New Era in Companion Diagnostics—Practical Considerations about Companion Diagnostics for Non-Small-Cell-Lung-Cancer
by: Till Plönes, et al.
Published: (2016-01-01) -
Alternate Antimicrobial Therapies and Their Companion Tests
by: Sriram Kalpana, et al.
Published: (2023-07-01) -
How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review
by: Mikyung Kelly Seo, et al.
Published: (2021-09-01) -
Aligning the Economic Value of Companion Diagnostics and Stratified Medicines
by: Edward D. Blair, et al.
Published: (2012-11-01) -
A Review of Intraocular Biomolecules in Retinal Vein Occlusion: Toward Potential Biomarkers for Companion Diagnostics
by: Bingjie Wang, et al.
Published: (2022-04-01)